secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2026-04-10T23:59:59+00:00
Accession:  0001919246-26-000058
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pelthos Therapeutics appoints John M. Gay as CFO, replaces Francis Knuettel II
------------------------------------------------------------------------------

- John M. Gay appointed CFO effective April 10, 2026; also named treasurer and secretary.
- Gay previously served as SVP, Finance & Accounting since July 2025; prior CFO at LNHC and Novan.
- Francis Knuettel II terminated as CFO effective April 10, 2026; no disagreement cited.
- Gay's employment agreement: $425,000 base salary, 40% target annual bonus.
- Press release issued April 10, 2026; CEO Scott Plesha cites strong commercial momentum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000191924626000058/0001919246-26-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000191924626000058/pths-20260410.htm
  HTML page:      https://secwatch.observer/filing/0001919246-26-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer